GST rejig may impact competitiveness of medical devices: AiMeD
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
Delegates also visited Emami’s WHO-GMP-certified manufacturing plant and Zandu Foundation for Healthcare farms for hands-on exposure to quality practices,
The company has improved access to quality healthcare for seniors across both urban and rural areas
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
This achievement is part of the population-based initiative for screening, prevention, and management of Non-Communicable Diseases
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
Nadda noted that on the basis of economic caste census, 50 crore people were brought under this scheme
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
 
        Subscribe To Our Newsletter & Stay Updated